Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Iron Deficiency Anemia Market from 2024 to 2025?
The market size for iron deficiency anemia has seen substantial growth in recent times. This growth is forecasted to continue, with market size increasing from $3.37 billion in 2024 to $3.58 billion in 2025, thus reflecting a compound annual growth rate (CAGR) of 6.3%. This uptrend observed in the historical period is due to factors such as initiatives from non-government organizations, a rise in chronic disease instances, heightened attention towards parental care, campaigns enlightening the public about nutritional deficiencies, and the wider reach of telemedicine.
What Is the Projected Market Size of the Iron Deficiency Anemia Market?
Anticipated robust expansion is on the cards for the iron deficiency anemia market in the coming years. By 2029, the market is projected to rise to a worth of $4.55 billion, with a compound annual growth rate (CAGR) of 6.2%. This anticipated growth during the forecast period can be credited due to increasing emphasis on female health, surging demand for less invasive treatments, availability of over-the-counter items, expansion of distribution networks, and increased acceptance of personalized medicine. Upcoming trends over the forecast phase include the creation of inventive drug delivery systems, advances in diagnostic equipment, progress in monitoring devices, development of combination therapies, and the incorporation of nanotechnology into drug delivery.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21212&type=smp
Who are the Major Competitors in the Iron Deficiency Anemia Market Outlook?
Major companies operating in the iron deficiency anemia market are AbbVie Inc., Sanofi S.A., Abbott Laboratories, Fresenius SE & Co. KGaA, Sandoz International GmbH, CSL Limited, Daiichi Sankyo Company Limited, Perrigo Company, Cipla Limited, Dr. Reddy’s Laboratories Limited, Cadila Healthcare Limited, Zydus Cadila, Lupin Limited, Alkem Laboratories Limited, AMAG Pharmaceuticals Inc., Akebia Therapeutics Inc., Rockwell Medical Inc., Pharmacosmos A/S, Shield Therapeutics plc, AdvaCare Pharma LLC
What Is Fueling Growth in the Iron Deficiency Anemia Market?
The rise in occurrences of nutritional insufficiencies is anticipated to drive the iron deficiency anemia market in the future. Nutritional insufficiency is a phenomenon that takes place when the body does not receive the adequate amount of one or more crucial nutrients, such as vitamins, minerals, proteins, or fats, needed for prime health. The instances of nutritional inadequacies are escalating due to poor food choices, amplified consumption of processed foods and issues relating to food security, thereby hampering access to nutrition-rich food sources for low-income communities. Iron deficiency anemia, a prevalent type of nutritional insufficiency, is characterized by a decrease in red blood cells due to insufficient iron intake, impeding the body’s capacity to transport oxygen. For instance, National Health Services, a United Kingdom-based government entity, reported in December 2023 that the total hospital admissions for nutritional insufficiencies in the United Kingdom in the year 2021/22 accounted for 250,000, that number doubled in the year 2022/23 and escalated to 500,000. Hence, the mounting cases of nutritional insufficiencies propel the iron deficiency anemia market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21212&type=smp
Which Iron Deficiency Anemia Market Segments Are Growing the Fastest?
The iron deficiency anemia market covered in this report is segmented –
1) By Therapy Type: Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion
2) By Distribution Channel: Hospital Pharmacy, Drug Stores and Retail Pharmacies, Online Pharmacies
3) By End Users: Hospitals, Clinics, Home Healthcare
Subsegments:
1) By Oral Iron Therapy: Ferrous Sulfate, Ferrous Gluconate, Ferrous Fumarate, Polysaccharide-Iron Complex, Carbonyl Iron
2) By Parenteral Iron Therapy: Iron Sucrose, Ferric Carboxymaltose, Iron Dextran, Ferumoxytol, Ferric Gluconate
3) By Red Blood Cell Transfusion: Leukocyte-Reduced Red Blood Cell Transfusion, Washed Red Blood Cell Transfusion, Irradiated Red Blood Cell Transfusion
Which Industry Trends Are Shaping the Future of the Iron Deficiency Anemia Market?
Leading businesses in the iron deficiency anemia market are directing their efforts towards the creation of pioneering solutions such as intravenous iron injection. Their aim is to provide an effective mix of nutrients that optimizes absorption and promotes tolerance, thus adequately addressing iron deficiency. The intravenous iron injection, a medical practice, delivers iron directly into the bloodstream as a remedy for iron deficiency or anemia when traditional oral supplements do not suffice or are inefficient. For example, Cadila Pharmaceuticals, a Pharmaceutical firm based in India, in March 2024, introduced Redshot FCM, an intravenous iron injection designed with ferric carboxymaltose specifically to address iron deficiency anemia (IDA) effectively. This novel product is well-suited for all adults and children above the age of one who cannot withstand oral iron supplements. Redshot FCM, with its robust safety record and negligible anaphylaxis risk, permits the delivery of high iron dosages within a single session, facilitating a swift rise in hemoglobin levels. This makes it particularly beneficial for risk-prone demographics like expectant women, senior citizens and cancer patients.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/iron-deficiency-anemia-global-market-report
Which Countries Are Leading the Iron Deficiency Anemia Market?
North America was the largest region in the iron deficiency anemia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iron deficiency anemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21212
This Report Delivers Insight On:
1. How big is the iron deficiency anemia market, and how is it changing globally?
2. Who are the major companies in the iron deficiency anemia market, and how are they performing?
3. What are the key opportunities and risks in the iron deficiency anemia market right now?
4. Which products or customer segments are growing the most in the iron deficiency anemia market?
5. What factors are helping or slowing down the growth of the iron deficiency anemia market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model